GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immatics NV (NAS:IMTX) » Definitions » Purchase Of Investment

Immatics NV (Immatics NV) Purchase Of Investment : $-691.20 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Immatics NV Purchase Of Investment?

Immatics NV's purchase of investment for the three months ended in Mar. 2024 was $-315.87 Mil. It means Immatics NV spent $315.87 Mil on purchasing investments. Immatics NV's purchase of investment for the trailing twelve months (TTM) ended in Mar. 2024 was $-691.20 Mil.

Compared with last quarter ($-126.83 Mil in Dec. 2023 ), Immatics NV spent more money on purchasing investments in Mar. 2024 ($-315.87 Mil).


Immatics NV Purchase Of Investment Historical Data

The historical data trend for Immatics NV's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immatics NV Purchase Of Investment Chart

Immatics NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial -86.46 -70.67 -12.77 -229.16 -452.92

Immatics NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.52 -111.15 -137.35 -126.83 -315.87

Immatics NV Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-691.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immatics NV Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Immatics NV's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Immatics NV (Immatics NV) Business Description

Traded in Other Exchanges
Address
Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Immatics NV (Immatics NV) Headlines

From GuruFocus